Tirzepatide, a dual GIP and GLP-1 receptor agonist, has gained widespread recognition for its effectiveness in promoting substantial weight loss by enhancing metabolic functions and controlling ...
Now, research finds this scenario is more likely if the patient is taking popular new weight-loss meds such as ... have suggested that people taking GLP-1 medications might face higher odds ...
Some results have been hidden because they may be inaccessible to you